Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001520262-26-000002

EVP R&D, Chief Medical Officer sold 4,000 shares at $28.00 ($112,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2026-01-02 Sale 10b5-1 −4,000 $28.00 $112,000 61,740 D: show line 1 in the form
Open-market sales · 4,000 sh · avg $28.00 · $112,000
Loading xslF345X05/form4.xml…